Overview
Andrea Pellagatti practices practicing medicine in Oxford, United Kingdom.
Ms. Pellagatti is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, and Chromosome 7p Deletion.
She is actively involved in clinical research, co-authoring 93 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Andrea Pellagatti
Is Andrea Pellagatti a top-rated expert for Myelodysplastic Syndrome (MDS)?
MediFind is an objective health platform that identifies experts based on real-world data. Andrea Pellagatti is classified as an Elite expert for Myelodysplastic Syndrome (MDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Andrea Pellagatti participate in research or clinical trials?
Yes. Andrea Pellagatti has published 93 articles and abstracts on conditions like Myelodysplastic Syndrome (MDS). You can view a list of Andrea Pellagatti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Myelodysplastic Syndrome (MDS)Ms. Pellagatti isElite. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Myeloid Leukemia (AML)Ms. Pellagatti isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Chromosome 7p DeletionMs. Pellagatti isAdvanced. Learn about Chromosome 7p Deletion.
- LeukemiaMs. Pellagatti isAdvanced. Learn about Leukemia.
- Experienced
- Aase SyndromeMs. Pellagatti isExperienced. Learn about Aase Syndrome.
- AnemiaMs. Pellagatti isExperienced. Learn about Anemia.
- Cat Eye SyndromeMs. Pellagatti isExperienced. Learn about Cat Eye Syndrome.
- Chromosome 5q DuplicationMs. Pellagatti isExperienced. Learn about Chromosome 5q Duplication.
- Chronic Myelogenous Leukemia (CML)Ms. Pellagatti isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Chronic Myelomonocytic Leukemia (CMML)Ms. Pellagatti isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Cri-Du-Chat SyndromeMs. Pellagatti isExperienced. Learn about Cri-Du-Chat Syndrome.
- Pure Red Cell AplasiaMs. Pellagatti isExperienced. Learn about Pure Red Cell Aplasia.
- Transient Erythroblastopenia of ChildhoodMs. Pellagatti isExperienced. Learn about Transient Erythroblastopenia of Childhood.